Skip to main content
logo
Senti Biosciences Holdings, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
0.3537
-0.0052 (-1.45%)
At close: Aug 7, 2026, 4:00 PM EDT
0.3420
-0.0117 (-3.31%)
Pre-market: Aug 10, 2026, 4:50 AM EDT

SNTI Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.020.02-2.564.292.76
Revenue Growth
----40.25%55.23%387.81%
Gross Profit
0.020.02-2.564.292.76
Operating Income
-57-68.78-61.04-92.73-62.08-40.45
Net Income
-51.55-61.44-52.79-71.06-58.21-55.32
Earnings Per Share
-1.92-2.73-12.03-18.80-22.30-190.00
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
8.9416.4248.2835.9398.5656.03
Total Debt
19.1428.8933.5437.6737.0922.73
Net Cash (Debt)
-10.21-12.4714.74-1.7461.4733.3
Net Cash Growth
----84.58%101.98%
Net Cash Per Share
-0.37-0.553.21-0.3923.54114.35

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-36.88-43.44-41.4-52.4-34.9-34.64
Capital Expenditures
--0.2-0.03-12.04-41.37-5.54
Free Cash Flow
-36.88-43.64-41.42-64.43-76.27-40.18
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%-100.00%100.00%100.00%
Operating Margin
-356238.00%-312632.00%--3620.73%-1448.53%-1464.90%
Pretax Margin
-323168.75%-279263.64%--3256.77%-1158.77%-2002.79%
Profit Margin
-323169.00%-279264.00%--3256.77%-1158.77%-2002.79%
FCF Margin
-230469.00%-198364.00%--2515.93%-1779.51%-1455.20%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
289.891459.75-11.7814.5023.09